skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Detection of protease and protease activity using a single nanocrescent SERS probe

Patent ·
OSTI ID:1351818

This invention pertains to the in vitro detection of proteases using a single peptide-conjugate nanocrescent surface enhanced Raman scattering (SERS) probes with at least nanomolar sensitivity. The probe enables detection of proteolytic activity in extremely small volume and at low concentration. In certain embodiments the probes comprise an indicator for the detection of an active protease, where the indicator comprises a nanocrescent attached to a peptide, where said peptide comprises a recognition site for the protease and a Raman tag attached to the peptide.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
9,145,575
Application Number:
13/752,069
OSTI ID:
1351818
Resource Relation:
Patent File Date: 2013 Jan 28
Country of Publication:
United States
Language:
English

References (31)

Raman-based system for DNA sequencing-mapping and other separations patent April 1994
Detection of protease and protease activity using a single nanoscrescent SERS probe patent January 2013
Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity patent April 2014
Development and validation of a quantitative ELISA for the measurement of PSA concentration journal March 2002
Time-resolved fluorescence imaging (TRFI) for direct immunofluorescence of PSA and alpha-1-antichymotrypsin in prostatic tissue sections journal May 1999
Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates: Amidolytic activity of prostatic acid phosphatase journal January 2002
Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia journal January 1999
Epidemiology of prostate cancer journal December 2003
A history of prostate cancer treatment journal May 2002
Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer journal July 2003
The role of prostate-specific antigen in the clinical evaluation of prostatic disease journal March 2004
Prostate cancer epidemiology journal March 2003
Detection of a Biomarker for Alzheimer's Disease from Synthetic and Clinical Samples Using a Nanoscale Optical Biosensor journal February 2005
Surface-enhanced Raman scattering on tunable plasmonic nanoparticle substrates journal December 2004
Magnetic Nanocrescents as Controllable Surface-Enhanced Raman Scattering Nanoprobes for Biomolecular Imaging journal November 2005
Nanowell surface enhanced Raman scattering arrays fabricated by soft-lithography for label-free biomolecular detections in integrated microfluidics journal August 2005
Optofluidic control using photothermal nanoparticles journal December 2005
High-Density Silver Nanoparticle Film with Temperature-Controllable Interparticle Spacing for a Tunable Surface Enhanced Raman Scattering Substrate journal January 2005
Nanophotonic Crescent Moon Structures with Sharp Edge for Ultrasensitive Biomolecular Detection by Local Electromagnetic Field Enhancement Effect journal December 2004
Enzymatic action of prostate-specific antigen (PSA or hK3): Substrate specificity and regulation by Zn2+, a tight-binding inhibitor journal October 2000
Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer. journal January 2003
Are multiple markers the future of prostate cancer diagnostics? journal July 2004
Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer journal June 2004
Epidemiology of prostate cancer: molecular and environmental clues journal November 1996
A Change of Wave-length in Light Scattering journal April 1928
Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences journal April 2002
Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate journal January 1998
Characterization of Prostate-Specific Antigen Proteolytic Activity on its Major Physiological Substrate, the Sperm Motility Inhibitor Precursor/Semenogelin I journal April 1997
Immunopeptidometric Assay for Enzymatically Active Prostate-Specific Antigen journal January 2004
Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography: PSA-Specific Peptides journal November 2003
The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease* journal April 2001